Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Your RPS

RPS Wales welcomes announcement of £100m transformation fund

The money will be directed towards making the improvements suggested by a parliamentary review of health and social care in Wales.

Health and social care worker


RPS Wales has welcomed the announcement of £100m Transformation Fund intended to improve the health and social care in Wales as suggested by a parliamentary review.

The Royal Pharmaceutical Society (RPS) in Wales has welcomed the news that the Welsh government will invest £100m to transform the nation’s health and social care services.

Details of the new Transformation Fund were announced by Vaughan Gething, Welsh cabinet secretary for health, social care and wellbeing, at the Welsh NHS Confederation’s annual conference on 7 February 2018.

Gething said that the money would be “heavily targeted at driving forward those changes to health and social care services that the Parliamentary Review [of Health and Social Care in Wales said were needed”.

The review, which was published in January 2018, made a series of recommendations on how to meet future challenges in health and social care.

“We recognise that radical and sustainable transformation of care can only be achieved through investment in new and innovative services, above and beyond the existing allocation of resources,” said Suzanne Scott-Thomas, chair of the RPS Welsh Pharmacy Board.

“We are determined that pharmacists must be part of transformative solutions in Wales, ensuring the expertise of the professions is fully embedded in the multiprofessional delivery of care.

“We will be making representations to the Welsh Government to outline where pharmacy innovation makes a difference across the care pathway from prevention of illness to acute care,” she added. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204421

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • International Research in Healthcare

    International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00Buy now
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Health and social care worker

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.